National Institute of Health (NIH) awards Aracari Biosciences to commercialize bone marrow platform that models in vivo drug responses
Aracari Biosciences, Inc. (“Aracari”) announced that it has received a grant from the National Institute of Health to further develop Aracari’s proprietary human bone marrow technology that models in vivo drug responses.
